Indolyl Oxoacetamide Analogues as Potent Pancreatic Lipase Inhibitors
Inventors:
Dr. Atish T. Paul , Pracheta Sengupta, SNC Sridhar, George Ginson
Current anti-obesity drugs lack safety and efficacy, necessitating the development of safer and more effective alternatives.
The invention provides a formulation comprising indolyl oxoacetamide compounds, presenting a potential solution for addressing obesity.
The invention introduces novel indolyl oxoacetamide compounds with specific structural features and their pharmaceutical formulations as potent pancreatic lipase inhibitors, offering a new approach to combat obesity.
Potential Indian Clients: Pharmaceutical Companies, Research Institute
Current TRL: NA
Funded by: NA
IPC: A23L, C07D
Domain: Pharmaceutical Development
This website uses cookies or similar technologies, to enhance your browsing experience.